Axa S.A. Sangamo Therapeutics, Inc Transaction History

Axa S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $509,046 - $797,964	458,600 New	458,600 $596,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $1.25 Million - $1.86 Million	291,800 New	291,800 $1.43 Million
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $523,328 - $820,105	-48,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $323,050 - $636,300	35,000 Added 267.18%	48,100 $751,000
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $12,194 - $16,224	1,300 Added 11.02%	13,100 $124,000
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $73,278 - $139,594	11,800 New	11,800 $106,000

118

43.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.